Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Natl India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Ranbaxy Laboratories Ltd

+ Add to Watchlist

RBXY:IN

859.80 INR 45.80 5.63%

As of 07:06:01 ET on 04/01/2015.

Snapshot for Ranbaxy Laboratories Ltd (RBXY)

Open: 814.70 Day's Range: 809.45 - 869.70 Volume: 5,723,924
Previous Close: 814.00 52wk Range: 429.05 - 869.70 1-Yr Rtn: -

Stock Chart for RBXY

No chart data available.
  • RBXY:IN 859.80
  • 1D
  • 1M
  • 1Y
814.00
Interactive RBXY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for RBXY

Current P/E Ratio (ttm) -
Estimated P/E(03/2015) 68.2164
Relative P/E vs. SENSEX -
Earnings Per Share (INR) (ttm) -
Est. EPS (INR) (03/2015) 12.6040
Est. PEG Ratio -
Market Cap (M INR) 365,985.46
Shares Outstanding (M) 425.66
30 Day Average Volume 817,811
Price/Book (mrq) 11.0192
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (INR) 2.0000
Dividend Ex-Date 04/28/2011
5 Year Dividend Growth -
Next Earnings Announcement 05/09/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for RBXY

No data available

Company Profile & Key Executives for RBXY

Ranbaxy Laboratories Limited manufactures and distributes a wide range of pharmaceutical products. The Company makes multisource antibiotics, analgesics, anti-inflammatory drugs and anti-ulcerant/gastrointestinal drugs such as "Roscillin" (Ampicillin), "Cifran" (Ciprofloxacin) and "Sporidex" (Cephalexin).

Arun SawhneyCEO/Managing DirectorIndrajit BanerjeePresident/CFO
Manjeet BindraChief Data Reliability OfficerRajiv GulatiPres:Global Pharmaceutical Bus
More Company Profile & Key Executives for RBXY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil